Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · IEX Real-Time Price · USD
+0.50 (1.10%)
May 17, 2024, 4:00 PM EDT - Market closed

Soleno Therapeutics Statistics

Total Valuation

SLNO has a market cap or net worth of $1.68 billion. The enterprise value is $1.53 billion.

Market Cap 1.68B
Enterprise Value 1.53B

Important Dates

The last earnings date was Thursday, May 9, 2024, after market close.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

SLNO has 36.41 million shares outstanding. The number of shares has increased by 283.26% in one year.

Shares Outstanding 36.41M
Shares Change (YoY) +283.26%
Shares Change (QoQ) +119.55%
Owned by Insiders (%) 1.27%
Owned by Institutions (%) 93.40%
Float 15.14M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 11.72
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.23, with a Debt / Equity ratio of 0.00.

Current Ratio 11.23
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -61.80% and return on invested capital (ROIC) is -37.27%.

Return on Equity (ROE) -61.80%
Return on Assets (ROA) -46.90%
Return on Capital (ROIC) -37.27%
Revenue Per Employee n/a
Profits Per Employee -$1.58M
Employee Count 33
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +973.49% in the last 52 weeks. The beta is -1.50, so SLNO's price volatility has been lower than the market average.

Beta (1Y) -1.50
52-Week Price Change +973.49%
50-Day Moving Average 42.42
200-Day Moving Average 31.49
Relative Strength Index (RSI) 56.33
Average Volume (30 Days) 420,391

Short Selling Information

The latest short interest is 3.41 million, so 9.38% of the outstanding shares have been sold short.

Short Interest 3.41M
Short Previous Month 3.10M
Short % of Shares Out 9.38%
Short % of Float 22.55%
Short Ratio (days to cover) 9.42

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -53.57M
Pretax Income -52.03M
Net Income -52.03M
EBITDA -49.76M
EBIT -52.03M
Earnings Per Share (EPS) -$2.06
Full Income Statement

Balance Sheet

The company has $149.63 million in cash and $347,000 in debt, giving a net cash position of $149.28 million or $4.10 per share.

Cash & Cash Equivalents 149.63M
Total Debt 347,000
Net Cash 149.28M
Net Cash Per Share $4.10
Equity / Book Value 143.39M
Book Value Per Share 3.94
Working Capital 137.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.74 million and capital expenditures -$11,000, giving a free cash flow of -$30.75 million.

Operating Cash Flow -30.74M
Capital Expenditures -11,000
Free Cash Flow -30.75M
FCF Per Share -$0.85
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SLNO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -283.26%
Shareholder Yield -283.26%
Earnings Yield -3.10%
FCF Yield -1.83%

Analyst Forecast

The average price target for SLNO is $60.33, which is 30.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target $60.33
Price Target Difference 30.70%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date Aug 26, 2022
Split Type Reverse
Split Ratio 1:15


Altman Z-Score n/a
Piotroski F-Score 2